本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Dicerna Pharmaceuticals, Inc.

38.22
0.0000
成交量:- -
成交額:2.13億
市值:29.86億
市盈率:-23.51
高:38.22
開:38.22
低:38.22
收:38.22
52周最高:40.14
52周最低:19.06
股本:7,812.94萬
流通股本:6,036.40萬
量比:- -
換手率:- -
股息:- -
股息率:- -
每股收益(TTM):-1.6258
每股收益(LYR):-1.5198
淨資產收益率:-95.22%
總資產收益率:-10.43%
市淨率:27.74
市盈率(LYR):-25.15

資料載入中...

2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/12/28

重要事件披露

8-K - Current report
2021/12/28

交易所摘牌聲明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2021/12/28

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/12/28

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/12/28

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/12/28

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/12/28

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/12/28

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/11/22

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/09

重要事件披露

8-K - Current report
2021/11/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/08/09

重要事件披露

8-K - Current report
2021/08/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/08/06

重要事件披露

8-K - Current report
2021/06/04

重要事件披露

8-K - Current report
2021/05/06

重要事件披露

8-K - Current report
2021/05/06

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/04/12

重要事件披露

8-K - Current report
2021/03/12

重要事件披露

8-K - Current report